Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration.
about
Measurements of Gluconeogenesis and Glycogenolysis: A Methodological ReviewEffects of insulin and cytosolic redox state on glucose production pathways in the isolated perfused mouse liver measured by integrated 2H and 13C NMR.20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects.Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.Increased gluconeogenesis in youth with newly diagnosed type 2 diabetesImpact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogsLoss of hepatic autoregulation after carbohydrate overfeeding in normal man.Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection.Glycogen branches out: new perspectives on the role of glycogen metabolism in the integration of metabolic pathways.HIF2α Is an Essential Molecular Brake for Postprandial Hepatic Glucagon Response Independent of Insulin Signaling.Brain Glucose Metabolism Controls Hepatic Glucose and Lipid Production.Dietary proteins contribute little to glucose production, even under optimal gluconeogenic conditions in healthy humans.Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart diseaseInhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose productionEvidence for a catabolic role of glucagon during an amino acid load.Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope studyCNS regulation of glucose homeostasis.Nutritional regulation of the anabolic fate of amino acids within the liver in mammals: concepts arising from in vivo studies.Molecular pathophysiology of hepatic glucose production.Protein: metabolism and effect on blood glucose levels.Gluconeogenesis in patients with impaired liver function.Hypothalamic sensing of circulating lactate regulates glucose production.Autoregulation of glucose production in men with a glycerol load during rest and exercise.Lack of hepatic "interregulation" during inhibition of glycogenolysis in a canine model.Mechanism of regulation of glucose production by lipolysis in humans.Evidence against glycogen cycling of gluconeogenic substrates in various liver preparations.Measurement of gluconeogenesis in exercising men by mass isotopomer distribution analysis.Metabolic and cardiorespiratory responses to "the lactate clamp".Lactate and glucose interactions during rest and exercise in men: effect of exogenous lactate infusion.Gluconeogenesis in humans with induced hyperlactatemia during low-intensity exercise.Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog.Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion.Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans.Gluconeogenesis and intrahepatic triose phosphate flux in response to fasting or substrate loads. Application of the mass isotopomer distribution analysis technique with testing of assumptions and potential problems.In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans.Hypoglycemia in patients with renal failure.
P2860
Q26776006-A7A91753-24B7-4FC6-BD5E-A69E3D69DBF0Q33227209-85BC72B1-6456-4A1E-A558-0EF77E27DF9AQ33636288-3D8F7A9D-AB25-4591-9E4A-E6F2A62B5665Q33836122-049CD38A-81FA-4017-9953-6A5CA118457AQ33900863-08B09916-0455-4424-92D1-4996C997B82CQ33903864-05D9AB9F-BE46-401F-AC37-373E3E605B2AQ34152244-615380F9-2E67-495D-85DE-01F2AF8EED3DQ34201786-2932E15B-32D8-4F04-8D1A-727AD3E653D4Q35071262-768B3993-76DF-480D-8BB3-E071F50B5069Q35516372-57E61860-6883-4C5D-8846-5A1B0CC710BBQ35764871-AB657A79-0943-43B0-A02B-DB1353E01BFBQ35768126-EADB0A11-8005-43B6-9B8B-81AFA8EB270CQ36396560-84C60980-793F-4AFC-9FAA-A25F38C237B6Q36669733-C4726F7F-4AC0-4846-BA44-F4C4F546327BQ36688433-545B2288-F29E-4392-B880-52577A1F6CB1Q36795941-98556A94-5973-43CF-BA57-F698902A445BQ37002532-A2F6374D-16F2-4B54-AD31-64A724928B0EQ37264148-C2D9D64E-88AC-4893-8864-A2EBA580F439Q37357010-B0A5AE86-F585-4BC5-AD34-C7A550177A55Q37372215-F658247F-B2D5-4C38-A53F-19D994F0DB0AQ37512891-E76A4B54-28C3-46BE-BA9B-3A46B3748529Q38544129-AB85493E-D314-490C-AF3D-E9B109F69180Q38628354-658B2FD4-DB18-417A-867A-D7A5E9B7CC94Q41672458-C5632B4D-DD6A-4DBA-97BB-9D0FED21691CQ41702735-645607D5-7B6E-4012-BB57-03A77B8A82FFQ41762010-5CBC972B-1B3B-478C-8EC5-9CACE469849BQ43545221-9C8DA458-B385-41B8-9D52-6B8FEC477EDDQ43664593-6E376D71-25CE-42D9-8D7E-8F8CD25B269CQ44007758-5411FC24-5E7F-498E-8F09-5383444A6088Q44013196-641B1E6F-F86F-46C8-86DC-5A845F00C766Q44031876-CB11792C-C320-403B-B3AA-2E1E10EF14CDQ44176889-398DA2DF-5573-4951-8109-9E88DC95F1DEQ44201765-7FEA9A47-6AD4-4938-AD33-DFD93BA1DBE1Q44327197-5A5F7C76-8884-4722-8965-0C808B29E32BQ44355151-2B084C97-91F6-4DB2-9640-0C0FC3D776DCQ44433214-1AFC8407-7B5E-47C2-884C-F625DC6A5E5EQ44575978-7350B8F5-D127-4A22-8E67-98B5D7165ECFQ44775417-D1803F1F-047A-4A2D-8008-150810B39AE4Q44945885-D28B6A57-C54E-4C66-8F3F-E3E58E37FDC5Q45144517-1F5EA9F8-EB7D-41EB-AB51-23570870142A
P2860
Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration.
description
1990 nî lūn-bûn
@nan
1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Failure of substrate-induced g ...... plasma glucose concentration.
@ast
Failure of substrate-induced g ...... plasma glucose concentration.
@en
Failure of substrate-induced g ...... plasma glucose concentration.
@nl
type
label
Failure of substrate-induced g ...... plasma glucose concentration.
@ast
Failure of substrate-induced g ...... plasma glucose concentration.
@en
Failure of substrate-induced g ...... plasma glucose concentration.
@nl
prefLabel
Failure of substrate-induced g ...... plasma glucose concentration.
@ast
Failure of substrate-induced g ...... plasma glucose concentration.
@en
Failure of substrate-induced g ...... plasma glucose concentration.
@nl
P2093
P2860
P356
P1476
Failure of substrate-induced g ...... plasma glucose concentration.
@en
P2093
P2860
P304
P356
10.1172/JCI114735
P407
P577
1990-08-01T00:00:00Z